Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08932_nanopub.RAJ8diWEiHJ4e9UhOsUKhf14p8EZgBdNz_LJI6URhe61o#assertion>. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB08932 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08932 label "MACITENTAN [drugbank:DB08932]" assertion.
- drugbank:DB08932 seeAlso DB08932 assertion.
- drugbank:DB08932 seeAlso macitentan.html assertion.
- drugbank:DB08932 seeAlso opsumit-drug.htm assertion.
- drugbank:DB08932 identifier "drugbank:DB08932" assertion.
- drugbank:DB08932 description "Macitentan was approved in October 2013. It is indicated for patients with pulmonary arterial hypertension, and is marketed under the brand name Opsumit. Macitentan is an antagonist/blocker of endothelin receptors on blood vessels and smooth muscle, and, thus, blocks the stimulation of vasculature hypertrophy, inflammation, fibrosis, proliferation, and vasoconstriction. Similar to all drugs acting on the renin-angiotensin system, macitentan is associated with embryo and fetal toxicity, so it should not be used in pregnancy and has special precautions that must be followed for all females of child-bearing age." assertion.
- drugbank:DB08932 title "MACITENTAN" assertion.
- drugbank:DB08932 bio2rdf_vocabulary:identifier "DB08932" assertion.
- drugbank:DB08932 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08932 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08932" assertion.
- drugbank:DB08932 bio2rdf_vocabulary:x-identifiers.org DB08932 assertion.
- drugbank:DB08932 drugbank_vocabulary:drugbank-id "DB08932" assertion.
- drugbank:DB08932 drugbank_vocabulary:x-cas cas:441798-33-0 assertion.
- drugbank:DB08932 drugbank_vocabulary:x-kegg kegg:D10135 assertion.
- drugbank:DB08932 drugbank_vocabulary:x-wikipedia wikipedia:Macitentan assertion.
- drugbank:DB08932 drugbank_vocabulary:x-ndc ndc:66215-501-30 assertion.